Quest Diagnostics

RxAlly

Survey: U.S. adults trust Internet more than pharmacist on health care decisions

Wednesday, October 10, 2012 09:51 AM

A new RxAlly survey revealed that only 18% of U.S. adults trust a pharmacist most to help guide and inform healthcare decisions for themselves and their families. A majority of people trust their doctor most 72%, followed by friends and family 36%, spouses or significant others 36% and the Internet 22%.

More... »


RxAlly adds Mike Groh as CIO

Thursday, August 2, 2012 03:33 PM

RxAlly, an alliance of more than 22,000 pharmacies nationwide, has appointed Michael J. Groh, PharmD, as chief information officer.

More... »


RxAlly names Tom O'Grady to leadership team

Tuesday, July 17, 2012 12:12 PM

RxAlly, a first-of-its-kind alliance of more than 22,000 pharmacies nationwide, has named Tom O'Grady to its leadership team.  As general counsel and executive vice president of corporate development, O’Grady brings more than 30 years of corporate and transactional law experience. He will be structuring business relationships between RxAlly and the companies and businesses it will be working with as it continues to align pharmacies and pharmacists, the patients they serve and the payer community.

More... »

RxAlly adds Peter Duran to leadership team

Friday, June 8, 2012 10:57 AM

RxAlly, a performance network of 22,000 aligned pharmacies nationwide, has named Peter C. Duran vice president and chief privacy officer.

More... »


CWWeekly

June 29

FDA and PatientsLikeMe collaborate to test social media adverse event reporting

Boston-area teaching hospitals launch web portal to attract life science companies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs